David T. Rubin, MD

FDA approves first oral treatment for moderately to severely active Crohn’s disease fda.gov/drugs/news-eve…

This year was the 14th year of @CrnstnsHlth Best of DDW in #IBD!
▶️ 40 faculty and fellows worked together to identify the best of the best from #DDW23
▶️ Coming soon to a city or webinar near you: CME programs (US/UK/Aus/NZ/Asia)!
▶️ We will announce dates and times soon

A Call to Action, US colleagues and people with #IBD, please take a minute:
crohnscolitisfoundation.org/get-involved/b…

Welcoming all my friends and colleagues to our beautiful city! #DDW23 ⁦@UChicagoGI⁩

I joined my colleagues and the @CrohnsColitisFn in developing this statement supporting the authority of the @US_FDA.
▶️Read our Mifepristone Decision Position Statement:
crohnscolitisfoundation.org/sites/default/…